Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

CHANGE IN RATINGS, EPS

Advanced Micro Devices

(AMD) - Get Advanced Micro Devices, Inc. Report

upgraded at UBS from Neutral to Buy. $9 price target. Expect improved execution to drive more sustainable margins.

Alexion Pharmaceuticals

(ALXN) - Get Alexion Pharmaceuticals, Inc. Report

numbers upped at ThinkEquity.ALXN estimates were boosted through 2012. Solaris approval should boost near-term growth. Buy rating and new $76 price target.

Alkermes

(ALKS) - Get Alkermes Plc Report

estimates, target raised at Jefferies.Shares of ALKS now seen reaching $21. New analyst also increased, as the Elan Drug acquisition should add to earnings. Buy rating.

Cintas

(CTAS) - Get Cintas Corporation Report

estimates increased at Morgan Stanley through 2013. Company is keeping a tight lid on costs, despite lower expected sales.

Clorox

(CLX) - Get Clorox Company Report

target reduced at BMO.Shares of CLX now seen reaching $62. Icahn premium will now likely come out of the stock. Market Perform rating.

DISH Network

(DISH) - Get DISH Network Corporation Class A Report

estimates, target cut at UBS.Shares of DISH now seen reaching $29. Estimates also lowered for streaming costs and TerreStar transaction. Neutral rating.

Estee Lauder

(EL) - Get Estee Lauder Companies Inc. Class A Report

upgraded at Stifel from Hold to Buy. $113 price target. Company should continue to gain market share.

Expedia

(EXPE) - Get Expedia Group, Inc. Report

upgraded at Piper from Neutral to Overweight. TripAdvisor spin-off should unlock value. International bookings are also ramping. $33 price target.

First Cash

(FCFS) - Get FirstCash, Inc. Report

downgraded at Sterne Agee from Neutral to Underperform. Relative valuation call, based on a $44 price target.

First Horizon

TheStreet Recommends

(FHN) - Get First Horizon National Corporation Report

upgraded at Morgan Stanley from Equal-weight to Overweight. $11 price target. Profitability should expand in the coming years.

Foster Wheeler

undefined

upgraded at BMO Capital to Outperform. $32 price target. Despite limited near-term visibility, the company should be an early-cycle recovery play.

Green Mountain Coffee

(GMCR)

rated new Buy at Argus. $130 price target. K-cups should continue to gain market share.

Itron

(ITRI) - Get Itron, Inc. Report

rated new Overweight at Morgan Stanley. $45 price target. Stock appears oversold at current levels.

Martin Marietta Materials

(MLM) - Get Martin Marietta Materials, Inc. (MLM) Report

upgraded at Longbow from Neutral to Buy. $77 price target. Highway spending should remain stable through 2012.

Marvell Technology

(MRVL) - Get Marvell Technology Group Ltd. Report

estimates, target increased at UBSShares of MRVL now seen reaching $19.50. Estimates also raised a storage and networking remain resilient.

MEMC Electronic

(WFR)

estimates reduced at JP Morgan through 2012. Company could face pricing pressure in the coming quarters. Underweight rating and $6.50 price target.

People's United

(PBCT) - Get People's United Financial, Inc. Report

downgraded at Morgan Stanley from Overweight to Equal-weight. $16 price target. See better value elsewhere in the sector.

PNM Resources

(PNM) - Get PNM Resources, Inc. Report

numbers boosted at Jefferies. Shares of PNM now seen reaching $18.50. Estimates also upped, as the sale of the company's non-regulated assets should add to earnings. Buy rating.

PNM Resources upgraded at Wells to Outperform. Company got a good price for its unregulated businesses.

United Technologies

undefined

cut from US 1 List at BofA/Merrill Lynch.

United Technologies upgraded at Morgan Stanley from Equal-weight to Overweight. $95 price target. Goodrich purchase should add to earnings.

United Technologies estimates, target lowered at UBS.Shares of UTX now seen reaching $91. Estimates also lowered on restructuring and deal costs. Buy rating.

End of report.

This article was written by a staff member of TheStreet.